Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02929524Phase 3Completed
Phase 3, randomised, double-blind trial in acute pain comparing Ketamine Group with Placebo Group (2 arms). Primary endpoint: Decreased venipuncture Time. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02929524.